Michelle R Lofwall

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. doi Efficacy of continuing medical education to reduce the risk of buprenorphine diversion
    Michelle R Lofwall
    Department of Psychiatry, University of Kentucky, Lexington, KY 40509, USA
    J Subst Abuse Treat 41:321-9. 2011
  2. pmc Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial
    Michelle R Lofwall
    University of Kentucky UK, Department of Psychiatry, Lexington, KY 40509, USA UK, Department of Behavioral Science, Lexington, KY 40502, USA UK, Center on Drug and Alcohol Research, Lexington, KY 40502, USA Electronic address
    Drug Alcohol Depend 133:188-97. 2013
  3. pmc Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine
    Michelle R Lofwall
    Department of Psychiatry, University of Kentucky College of Medicine, Lexington, KY, United States
    Drug Alcohol Depend 126:379-83. 2012
  4. pmc Effects of cold pressor pain on the abuse liability of intranasal oxycodone in male and female prescription opioid abusers
    Michelle R Lofwall
    University of Kentucky, Department of Psychiatry, Lexington, KY 40509, USA
    Drug Alcohol Depend 123:229-38. 2012
  5. pmc Abuse liability and reinforcing efficacy of oral tramadol in humans
    Shanna Babalonis
    University of Kentucky College of Medicine, Department of Behavioral Science, Lexington, KY 40536 0086, United States
    Drug Alcohol Depend 129:116-24. 2013
  6. pmc Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies
    William W Stoops
    Department of Behavioral Science, University of Kentucky College of Medicine, 140 Medical Behavioral Science Building, Lexington, KY 40536 0086, USA
    Psychopharmacology (Berl) 212:193-203. 2010
  7. pmc Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment
    William W Stoops
    Department of Behavioral Science, University of Kentucky College of Medicine, 140 Medical Behavioral Science Building, Lexington, KY 40536 0086, USA
    Psychopharmacology (Berl) 223:427-38. 2012
  8. ncbi Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers
    Sharon L Walsh
    Center on Drug and Alcohol Research, University of Kentucky, Lexington, KY 40503, USA
    Addict Biol 18:332-43. 2013
  9. pmc The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers
    Sharon L Walsh
    Department of Behavioral Sciences, Center on Drug and Alcohol Research, University of Kentucky, 515 Oldham Court, Lexington, KY 40502, USA
    Drug Alcohol Depend 98:191-202. 2008
  10. doi Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial
    Sharon L Walsh
    Center on Drug and Alcohol Research, Department of Behavioral Science, University of Kentucky College of Medicine, 515 Oldham Court, Lexington, KY 40502, United States
    Drug Alcohol Depend 130:150-7. 2013

Detail Information

Publications19

  1. doi Efficacy of continuing medical education to reduce the risk of buprenorphine diversion
    Michelle R Lofwall
    Department of Psychiatry, University of Kentucky, Lexington, KY 40509, USA
    J Subst Abuse Treat 41:321-9. 2011
    ..Mandatory CME targeting OBOT-certified physicians could have a positive impact on patient and public health outcomes...
  2. pmc Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial
    Michelle R Lofwall
    University of Kentucky UK, Department of Psychiatry, Lexington, KY 40509, USA UK, Department of Behavioral Science, Lexington, KY 40502, USA UK, Center on Drug and Alcohol Research, Lexington, KY 40502, USA Electronic address
    Drug Alcohol Depend 133:188-97. 2013
    ..The purpose of this study was to evaluate: (1) the efficacy of extended-release (ER) tramadol in treating prescription opioid withdrawal and (2) whether cessation of ER tramadol produces opioid withdrawal...
  3. pmc Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine
    Michelle R Lofwall
    Department of Psychiatry, University of Kentucky College of Medicine, Lexington, KY, United States
    Drug Alcohol Depend 126:379-83. 2012
    ..The study purpose was to examine frequency and source of and risk factors for diverted buprenorphine use over a 6-month period in an Appalachian community sample of prescription opioid abusers...
  4. pmc Effects of cold pressor pain on the abuse liability of intranasal oxycodone in male and female prescription opioid abusers
    Michelle R Lofwall
    University of Kentucky, Department of Psychiatry, Lexington, KY 40509, USA
    Drug Alcohol Depend 123:229-38. 2012
    ..The purpose of this study was to determine whether pain alters the intranasal abuse liability of oxycodone, a commonly prescribed and abused analgesic, in males and females...
  5. pmc Abuse liability and reinforcing efficacy of oral tramadol in humans
    Shanna Babalonis
    University of Kentucky College of Medicine, Department of Behavioral Science, Lexington, KY 40536 0086, United States
    Drug Alcohol Depend 129:116-24. 2013
    ..The purpose of this study was to examine the relative abuse liability and reinforcing efficacy of tramadol in comparison to a high (oxycodone) and low efficacy (codeine) opioid agonist...
  6. pmc Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies
    William W Stoops
    Department of Behavioral Science, University of Kentucky College of Medicine, 140 Medical Behavioral Science Building, Lexington, KY 40536 0086, USA
    Psychopharmacology (Berl) 212:193-203. 2010
    ....
  7. pmc Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment
    William W Stoops
    Department of Behavioral Science, University of Kentucky College of Medicine, 140 Medical Behavioral Science Building, Lexington, KY 40536 0086, USA
    Psychopharmacology (Berl) 223:427-38. 2012
    ..Tramadol is thought to have limited abuse potential compared to mu opioid agonists, but laboratory data indicate that it shares some of their pharmacodynamic effects...
  8. ncbi Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers
    Sharon L Walsh
    Center on Drug and Alcohol Research, University of Kentucky, Lexington, KY 40503, USA
    Addict Biol 18:332-43. 2013
    ..All dose combinations were safely tolerated. These findings are discussed in the context of the potential utility of NK1 antagonists in the treatment of opioid use disorders...
  9. pmc The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers
    Sharon L Walsh
    Department of Behavioral Sciences, Center on Drug and Alcohol Research, University of Kentucky, 515 Oldham Court, Lexington, KY 40502, USA
    Drug Alcohol Depend 98:191-202. 2008
    ....
  10. doi Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial
    Sharon L Walsh
    Center on Drug and Alcohol Research, Department of Behavioral Science, University of Kentucky College of Medicine, 515 Oldham Court, Lexington, KY 40502, United States
    Drug Alcohol Depend 130:150-7. 2013
    ..Preclinical and clinical evidence suggests that noradrenergic activity may play a role in mediating some effects of cocaine and may be a rational target for treatment...
  11. pmc Intranasal oxycodone self-administration in non-dependent opioid abusers
    Lisa S Middleton
    Department of Behavioral Science, University of Kentucky, Lexington, KY 40502, USA
    Exp Clin Psychopharmacol 20:310-7. 2012
    ....
  12. pmc The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
    Lisa S Middleton
    Departments of Behavioral Science, University of Kentucky, Lexington, KY 40502, USA
    Addiction 106:1460-73. 2011
    ..The study objectives were to characterize and compare their intranasal pharmacodynamic and pharmacokinetic profiles...
  13. ncbi Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults
    Michelle R Lofwall
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, USA
    Exp Clin Psychopharmacol 14:439-49. 2006
    ....
  14. pmc Changing profile of abused substances by older persons entering treatment
    Michelle R Lofwall
    Department of Psychiatry, University of Kentucky College of Medicine, Lexington, Kentucky 40509, USA
    J Nerv Ment Dis 196:898-905. 2008
    ..Efforts to determine best practices for prevention, identification, and treatment of illicit drug abuse in older persons are indicated...
  15. ncbi Experimentally-induced spontaneous opiate withdrawal: relationship to cigarette craving and expired air carbon monoxide
    Michelle R Lofwall
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Addict 16:310-5. 2007
    ..Interestingly, craving was only reduced for items related to the positive reinforcing effects of smoking. These preliminary results suggest that OW may be a favorable context to initiate smoking cessation treatment interventions...
  16. ncbi Modest opioid withdrawal suppression efficacy of oral tramadol in humans
    Michelle R Lofwall
    Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Psychopharmacology (Berl) 194:381-93. 2007
    ..Tramadol is in an unscheduled atypical analgesic with low rates of diversion and abuse and mixed pharmacologic actions, including modest opioid agonist activity...
  17. pmc Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans
    Michelle R Lofwall
    Department of Behavioral Science, Center on Drug and Alcohol Research
    Exp Clin Psychopharmacol 22:238-47. 2014
    ..The smoking abstinence procedure reliably produced nicotine withdrawal and craving and increased smoking modestly. These data do not support further investigation of aripiprazole for cocaine or tobacco use disorder treatment...
  18. pmc Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users
    Jennifer R Havens
    Center on Drug and Alcohol Research, Department of Behavioral Science, University of Kentucky College of Medicine, Lexington, KY 40504, USA
    Am J Public Health 103:e44-52. 2013
    ..We determined the factors associated with hepatitis C (HCV) infection among rural Appalachian drug users...
  19. ncbi The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance
    William W Stoops
    Department of Behavioral Science, University of Kentucky Medical Center, Lexington, Kentucky 40536 0086, USA
    Am J Drug Alcohol Abuse 33:769-76. 2007
    ..Aripiprazole was generally devoid of effects, but did alter temperature-increasing and subject-rated effects of cocaine as a function of cocaine dose...